nimbolide has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HY; Hsieh, SC; Hsieh, YH; Lee, CH; Lin, CL; Tsai, JP | 1 |
| Aggarwal, BB; Gupta, SC; Hema, PS; Nair, M; Park, B; Phromnoi, K; Reuter, S | 1 |
2 other study(ies) available for nimbolide and Kidney Neoplasms
| Article | Year |
|---|---|
Induction of cell cycle arrest, DNA damage, and apoptosis by nimbolide in human renal cell carcinoma cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; DNA Damage; G2 Phase Cell Cycle Checkpoints; Humans; Kidney Neoplasms; Limonins; Signal Transduction | 2015 |
Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Colonic Neoplasms; Extracellular Signal-Regulated MAP Kinases; HCT116 Cells; HT29 Cells; Humans; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Limonins; Lung Neoplasms; Multiple Myeloma; Pancreatic Neoplasms; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53 | 2011 |